Ameriprise
ABUS icon

Ameriprise’s Arbutus Biopharma ABUS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$35.4K Sell
11,440
-7,361
-39% -$22.7K ﹤0.01% 3896
2025
Q1
$65.6K Sell
18,801
-116
-0.6% -$405 ﹤0.01% 3889
2024
Q4
$61.9K Buy
+18,917
New +$61.9K ﹤0.01% 3965
2023
Q4
Sell
-98,000
Closed -$199K 3895
2023
Q3
$199K Hold
98,000
﹤0.01% 3707
2023
Q2
$225K Sell
98,000
-1,100
-1% -$2.53K ﹤0.01% 3696
2023
Q1
$300K Buy
99,100
+6,100
+7% +$18.5K ﹤0.01% 3610
2022
Q4
$217K Sell
93,000
-43,300
-32% -$101K ﹤0.01% 3683
2022
Q3
$260K Buy
136,300
+29,300
+27% +$55.9K ﹤0.01% 3627
2022
Q2
$290K Sell
107,000
-1,907
-2% -$5.17K ﹤0.01% 3567
2022
Q1
$324K Buy
108,907
+3,521
+3% +$10.5K ﹤0.01% 3614
2021
Q4
$410K Buy
105,386
+40,825
+63% +$159K ﹤0.01% 3577
2021
Q3
$277K Sell
64,561
-1,060
-2% -$4.55K ﹤0.01% 3600
2021
Q2
$199K Sell
65,621
-91,407
-58% -$277K ﹤0.01% 3749
2021
Q1
$523K Sell
157,028
-480,264
-75% -$1.6M ﹤0.01% 3382
2020
Q4
$2.26M Sell
637,292
-18,207
-3% -$64.6K ﹤0.01% 2724
2020
Q3
$2.05M Buy
+655,499
New +$2.05M ﹤0.01% 2651
2018
Q4
Sell
-104,506
Closed -$987K 3633
2018
Q3
$987K Buy
+104,506
New +$987K ﹤0.01% 3078
2017
Q3
Sell
-13,349
Closed -$48K 3655
2017
Q2
$48K Sell
13,349
-41,609
-76% -$150K ﹤0.01% 3676
2017
Q1
$179K Sell
54,958
-1,370
-2% -$4.46K ﹤0.01% 3479
2016
Q4
$138K Sell
56,328
-9,153
-14% -$22.4K ﹤0.01% 3725
2016
Q3
$225K Sell
65,481
-1,196
-2% -$4.11K ﹤0.01% 3513
2016
Q2
$232K Sell
66,677
-794
-1% -$2.76K ﹤0.01% 3478
2016
Q1
$279K Sell
67,471
-562
-0.8% -$2.32K ﹤0.01% 3387
2015
Q4
$303K Buy
68,033
+39,492
+138% +$176K ﹤0.01% 3466
2015
Q3
$174K Sell
28,541
-40,030
-58% -$244K ﹤0.01% 3642
2015
Q2
$813K Buy
68,571
+3,331
+5% +$39.5K ﹤0.01% 3179
2015
Q1
$1.14M Buy
+65,240
New +$1.14M ﹤0.01% 2873
2014
Q2
Sell
-95,914
Closed -$2.06M 5546
2014
Q1
$2.06M Buy
+95,914
New +$2.06M ﹤0.01% 2478